Benzinga
Benzinga
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Benzinga
martes, noviembre 17
Noticias de España
Acciones
Índices
Bonos
ETFs
Economía
General
Noticias de EE.UU.
Acciones
Índices
Ganancias
Economía
Mercados de predicción
Mercados privados
Otros mercados
Calificaciones de analistas
Trading
Comunicados de prensa
Noticias Mundiales
Europa
Asia
Latinoamérica
Criptomonedas
Noticias
Altcoins
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Formación
Invertir en criptomonedas
Invertir en acciones
Forex
Omada Health Inc
OMDA
NASDAQ
Lista de seguimiento
Get Report
Trade with Public
Get Report
Trade with Public
$14.08
-0.41
-2.83%
al cierre: Nov 17, 4:00 PM EST
$14.04
-0.04
-0.28%
After hour: 4:33 PM EST
Get Report
Panorámica general
Noticias
Gráficos
Previsión de beneficios
Eventos
Precios objetivo
Finanzas
Sentimiento
Propiedad
Comparar
Opciones
Informe de acciones
Omada Health Financials
Omada Health (OMDA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Omada Health Raises FY2026 Sales Guidance from $334.000M-$340.000M to $344.000M-$346.000M vs $338.537M Est
Omada Health (NASDAQ:OMDA) raises FY2026 sales outlook from $334.000 million-$340.000 million to $344.000 million-$346.000 million vs $338.537 million estimate.
Benzinga Newsdesk
PRO
Omada Health Q3 EPS $0.10 Beats $0.02 Estimate, Sales $91.000M Beat $85.676M Estimate
Omada Health (NASDAQ:OMDA) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.02 by 400 percent. This is a 600 percent increase over losses of $(0.02) per share from the same
Benzinga Newsdesk
PRO
Omada Health Raises FY2026 Sales Guidance from $322.000M-$330.000M to $334.000M-$340.000M vs $327.789M Est
Omada Health (NASDAQ:OMDA) raises FY2026 sales outlook from $322.000 million-$330.000 million to $334.000 million-$340.000 million vs $327.789 million estimate.
Benzinga Newsdesk
PRO
Omada Health Q2 EPS $0.08 Beats $(0.01) Estimate, Sales $87.835M Beat $80.190M Estimate
Omada Health (NASDAQ:OMDA) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $(0.01) by 900 percent. This is a 133.33 percent increase over losses of $(0.24) per share from the
Benzinga Newsdesk
PRO
Omada Health Raises FY2026 Sales Guidance from $312.000M-$322.000M to $322.000M-$330.000M vs $318.789M Est.
Omada Health (NASDAQ:OMDA) raises FY2026 sales outlook from $312.000 million-$322.000 million to $322.000 million-$330.000 million vs $318.789 million estimate.
Benzinga Newsdesk
PRO
Omada Health Q1 EPS $(0.05) Beats $(0.09) Estimate, Sales $78.048M Beat $74.036M Estimate.
Omada Health (NASDAQ:OMDA) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.09) by 44.44 percent. This is a 95.65 percent increase over losses of $(1.15) per share from the
Benzinga Newsdesk